Research programs
Compound screening, biologic development, assays and biomarkers. We examine the technical questions, experiments and records behind each program.
We help connect the research, financial records and funding arrangements behind your development programs with the specialist review your business needs.
Industry context
Research teams and financial leaders often work with different records and different deadlines. We take time to understand the projects, funding arrangements and business priorities before defining the review.
The aim is a clear account of the work performed, the information supporting it and the questions that still need to be resolved.
Compound screening, biologic development, assays and biomarkers. We examine the technical questions, experiments and records behind each program.
Stability trials, delivery formats and the move from bench-scale work to pilot or commercial production. The technical challenges can change as production grows.
Analytical tools, computational models and proprietary research platforms. We look at the development work and the technical problems it addresses.
We define the engagement around the questions you need answered and the information available.
Understand the projects and the work undertaken before assessing potential incentives. Scientific activity still needs to be evaluated against the relevant tax requirements.
Connect activities with available cost records and review the terms of outside research and funding agreements.
Help work through go-to-market priorities, administrative needs and operating systems within an agreed advisory scope.
A closer look
The terms of grants, collaborations and customer agreements can affect the questions a tax review must address. We ask for those agreements early and coordinate with your advisers where their interpretation needs further attention.
Preparing to talk
Bring a summary of current and recent programs, the entities involved, relevant funding or collaboration agreements and the people responsible for technical and financial records.
You do not need to assemble a full study before speaking with us. The initial conversation helps establish whether there is a useful scope for Royse and what the next step would involve.
These points help frame the discussion. Conclusions depend on the engagement facts.
No. The agreement, activities, rights and obligations need to be examined along with the applicable tax rules. A funding label alone is not enough to determine the outcome.
The proposed advisory work does not replace scientific review, clinical advice or regulatory counsel. Specialist responsibilities are identified and agreed when the engagement is scoped.